SERA PROGNOSTICS, INC.
Qualité des données : 100%
SERA
NASDAQ
Services
Health Services
1,97 €
▼
0,12 €
(-5,74%)
Cap. Boursière: 84,16 M
Prix
2,15 €
Cap. Boursière
84,16 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—
Quick Summary
Points Clés
Revenue declined -0,31% annually over 5 years
Negative free cash flow of -26,35 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 5,50%
Capital intensive — 896,30% of revenue goes to capex
Croissance
Revenue Growth (5Y)
-0,31%
En dessous de la moyenne du secteur (4,21%)
Revenue (1Y)5,19%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-37,47%
En dessous de la moyenne du secteur (-15,97%)
ROIC-33,37%
Net Margin-39417,28%
Op. Margin-45066,67%
Sécurité
Debt / Equity
N/A
Current Ratio1,89
Interest Coverage-4056,00
Valorisation
PE (TTM|NTM)
-2,64 | -2,94
En dessous de la moyenne du secteur (-1,19)
P/B Ratio1,02
EV/EBITDAN/A
Dividend YieldN/A
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Services (515 pairs)
Comparaison Sectorielle
vs médiane du secteur Services (515 pairs)| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -2,6 | -1,2 |
| P/B | 1,0 | 1,4 |
| ROE % | -37,5 | -16,0 |
| Net Margin % | -39417,3 | -19,4 |
| Rev Growth 5Y % | -0,3 | 4,2 |
| D/E | — | 0,4 |
Objectif de Cours des Analystes
1 analyste
Buy
Actuel
1,97 €
Objectif
5,00 €
5,00 €
5,00 €
5,00 €
Prévisions
P/E Prévisionnel
-2,94
BPA Prévisionnel
-0,67 €
CA Est.
2,17 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2027 |
-0,67 €
-0,68 € – -0,66 €
|
2,17 M | 2 |
| FY2026 |
-0,68 €
-0,73 € – -0,63 €
|
348 000,0 | 2 |
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| 2026 Q2 |
-0,18 €
-0,19 € – -0,16 €
|
76 670,0 | 3 |
| 2026 Q1 |
-0,17 €
-0,18 € – -0,16 €
|
96 670,0 | 3 |
Surprises de Résultats
Derniers 4 trimestres
| Trimestre | BPA Est. | BPA Réel | Surprise |
|---|---|---|---|
| Q42025 | -0,19 € | -0,16 € | +15,8% |
| Q32025 | -0,21 € | -0,16 € | +23,8% |
| Q22025 | -0,24 € | -0,16 € | +33,3% |
| Q12025 | -0,21 € | -0,20 € | +4,8% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5,19% | Revenue Growth (3Y) | -48,55% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -0,31% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 81 000,0 | Net Income (TTM) | -31,93 M |
| ROE | -37,47% | ROA | -29,03% |
| Gross Margin | N/A | Operating Margin | -45066,67% |
| Net Margin | -39417,28% | Free Cash Flow (TTM) | -26,35 M |
| ROIC | -33,37% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1,89 |
| Interest Coverage | -4056,00 | Asset Turnover | 0,00 |
| Working Capital | 20,99 M | Tangible Book Value | 81,24 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -2,64 | Forward P/E | -2,94 |
| P/B Ratio | 1,02 | P/S Ratio | 1039,00 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 38,72 | Fwd Earnings Yield | N/A |
| FCF Yield | -31,31% | ||
| Market Cap | 84,16 M | Enterprise Value | 80,08 M |
| Per Share | |||
| EPS (Diluted TTM) | -0,67 | Revenue / Share | 0,00 |
| FCF / Share | -0,67 | OCF / Share | -0,65 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 896,30% | FCF Conversion | 82,53% |
| SBC-Adj. FCF | -32,12 M | Growth Momentum | 5,50 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 81 000,0 | 77 000,0 | 306 000,0 | 268 000,0 | 82 000,0 |
| Net Income | -31,93 M | -32,90 M | -36,24 M | -44,19 M | -35,01 M |
| EPS (Diluted) | -0,67 | -0,99 | -1,16 | -1,43 | -2,33 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -36,50 M | -36,64 M | -39,82 M | -45,65 M | -35,40 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 13,17 M | 14,73 M | 15,23 M | 14,24 M | 11,02 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | 940 000,0 | 833 000,0 | 900 000,0 | 756 000,0 | 659 000,0 |
| Interest Expense | 9 000,0 | 28 000,0 | — | — | — |
| Income Tax | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 101,93 M | 72,58 M | 95,44 M | 116,33 M | 147,03 M |
| Total Liabilities | 26,53 M | 24,77 M | 25,28 M | 17,39 M | 8,47 M |
| Shareholders' Equity | 75,41 M | 47,80 M | 70,16 M | 98,94 M | 138,56 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 3,94 M | 4,04 M | 3,88 M | 29,88 M | 58,93 M |
| Current Assets | 40,77 M | 47,60 M | 61,34 M | 90,13 M | 110,25 M |
| Current Liabilities | 24,19 M | 24,77 M | 24,44 M | 15,54 M | 8,41 M |
{"event":"ticker_viewed","properties":{"ticker":"SERA","listing_kind":"stock","pathname":"/stocks/sera","exchange":"NASDAQ","country":"US"}}